Takeda Pharmaceutical Company Limited
INHIBITORS OF BETA-ARRESTIN-NEUROKININ 1 RECEPTOR INTERACTIONS FOR THE TREATMENT OF PAIN
Last updated:
Abstract:
The present invention relates to compounds and their uses. In particular, to compounds that inhibit the interaction between .beta.-arrestin and the intracellular C-terminus of the activated NK1R and their use in the treatment of pain.
Status:
Application
Type:
Utility
Filling date:
23 Feb 2017
Issue date:
2 Jul 2020